4
Changes in Ownership
Gossamer Bio, Inc. Filed Acc 0002003059-26-000008
Options or other derivatives
- Chief Commercial Officer acquired 5,800,051 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Smith Robert Paul JR Chief Commercial Officer | 2026-08-24 | Grant or award · Stock Option (Right to Buy) | +5,800,051 | 5,800,051 | D | ||
Loading xslF345X06/wk-form4_1787782286.xml…